This lab test package from Netmeds is designed to help detect and monitor markers in the blood that may indicate the presence of certain types of cancer common in women. It includes tests that measure specific proteins and blood components which can change when cancer develops or progresses. The package helps provide an overview of a woman's health status related to cancer risks, especially ovarian and other female-specific cancers, by assessing multiple important markers together. This screening supports early detection efforts and health monitoring but does not diagnose cancer on its own. It is important to follow test requirements and consult healthcare professionals for interpretation and further action. The description is created to be easy to understand and follows Indian healthcare guidelines for trustworthy and compliant health information.

What’s Included in my Package?

This package includes the following tests, each providing key insights into different cancer markers and blood health:

Test Name	What It Checks
Alpha Feto Protein (AFP) (1)	Measures a protein linked to liver and ovarian cancers
Cancer Antigen 125 (CA 125) (1)	Checks a tumor marker mainly for ovarian cancer
Carcinoembryonic Antigen (CEA) (2)	Detects levels linked with several cancer types including breast & colon
Complete Blood Count (CBC) with ESR (1)	Assesses overall blood health and inflammation which can indicate disease

Together, these tests help screen for various cancer types and detect changes in blood that might suggest health concerns. Combining tumor markers with blood count tests gives a more complete picture of the body's status to support screening and monitoring.

Why Get this Cancer Screening Profile - Female?

Early detection: Helps identify cancer-related changes in blood before symptoms appear.
Comprehensive overview: Multiple tests combined give a fuller picture of health.
Convenient: Bundled testing saves time and effort compared to separate tests.
Suitable for monitoring: Useful for women with family history or previous cancer.
Trusted platform: Netmeds provides accurate, guideline-aligned testing with easy access.

Who Should Get This?

This package suits preventive health check-ups focusing on female-specific cancer risk markers.

Women with a family history of ovarian or breast cancers benefit by early monitoring through these markers.
Individuals experiencing symptoms such as unexplained weight loss, fatigue, or abdominal discomfort that need cancer risk assessment.
Women aged 40 and above who want regular cancer screening aligned with Indian healthcare recommendations.
Those undergoing follow-up after cancer treatment to help monitor for recurrence signs.
Women seeking a comprehensive blood health check to understand overall wellness and inflammation levels.

This package specifically addresses common cancer risks faced by Indian women and their health concerns.

Additional Information

This screening is a health assessment tool and cannot diagnose cancer; abnormalities need follow-up with a doctor.
If test results are abnormal, consult a qualified healthcare professional for diagnosis and treatment decisions.
Maintaining a healthy lifestyle, balanced diet, and regular check-ups help complement screening efforts for women’s health.

Disclaimer: This package is for health screening and monitoring only. Please consult a qualified healthcare professional for diagnosis and treatment decisions.

Test Requirements

Sample required: Blood
Preparation: Overnight fasting for 10-12 hours is recommended to ensure accurate results.

FAQs

Q1: What is the role of Cancer Antigen 125 (CA 125) in this package?
CA 125 helps detect ovarian cancer markers, especially useful in women at risk or with symptoms, aiding early detection and monitoring

Q2: How does this package provide a comprehensive health picture?
Combining AFP, CA 125, CEA, and CBC with ESR tests allows assessment of multiple cancer risk factors and general blood health in one package

Q3: Are these tests done on blood or urine samples?
All tests in this package require blood samples only, simplifying the preparation and collection process

Q4: Can pregnant women take this package?
Pregnant women should consult their doctor as some markers like AFP can be elevated in pregnancy, affecting interpretation

Q5: When should I retest after an abnormal report?
Retesting depends on your doctor’s advice; usually, follow-ups happen within weeks to months to monitor changes appropriately

Cancer Screening Profile - Female

Test provided by

Sample collection from

Test requirements

Doctor VerifiedReports

30+ Years of experience

Millions Happy Customers

Doctor Verified
Reports

30+ Years of
experience

Millions Happy
Customers